New Enterprise Associates 14, L.P.
CIK 0001544328 Name as filed on the most recent filing
Filed as New Enterprise Associates 14, L.P. (32)
60 transaction lines · from 32 filings · filed 2014-08-06 to 2022-04-07 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Imara Inc. 10 filings
- ISSUER Surface Oncology, Inc. 2 filings
- ISSUER Mersana Therapeutics, Inc. 3 filings
- ISSUER Champions Oncology, Inc. 1 filings
- ISSUER Casper Sleep Inc. 1 filings
- ISSUER Galera Therapeutics, Inc. 1 filings
- ISSUER Oyster Point Pharma, Inc. 1 filings
- ISSUER Adaptimmune Therapeutics PLC 4 filings
- ISSUER Tracon Pharmaceuticals, Inc. 3 filings
- ISSUER Appian Corp 2 filings
- ISSUER Interleukin Genetics Inc 2 filings
- ISSUER Mirna Therapeutics, Inc. 1 filings
- ISSUER Loxo Oncology, Inc. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
2 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2022-04-06 |
Imara Inc. IMRA |
S, Open-market sale | 255,463 disposed | 1.10 | 281,826.78 | Form 4, filing 0001209191-22-023686 | |
| 2022-04-05 |
Imara Inc. IMRA |
S, Open-market sale | 439,088 disposed | 1.07 | 469,428.98 | Form 4, filing 0001209191-22-023686 | |
| 2022-01-25 |
Imara Inc. IMRA |
S, Open-market sale | 102,952 disposed | 1.47 | 151,802.72 | Form 4, filing 0001209191-22-004877 | |
| 2022-01-24 |
Imara Inc. IMRA |
S, Open-market sale | 19,984 disposed | 1.55 | 31,017.17 | Form 4, filing 0001209191-22-004877 | |
| 2022-01-21 |
Imara Inc. IMRA |
S, Open-market sale | 11,622 disposed | 1.67 | 19,388.98 | Form 4, filing 0001209191-22-004877 | |
| 2022-01-20 |
Imara Inc. IMRA |
S, Open-market sale | 6,295 disposed | 1.81 | 11,385.14 | Form 4, filing 0001209191-22-004110 | |
| 2022-01-19 |
Imara Inc. IMRA |
S, Open-market sale | 13,412 disposed | 1.82 | 24,413.86 | Form 4, filing 0001209191-22-004110 | |
| 2022-01-18 |
Imara Inc. IMRA |
S, Open-market sale | 6,848 disposed | 1.89 | 12,926.97 | Form 4, filing 0001209191-22-004110 | |
| 2022-01-14 |
Imara Inc. IMRA |
S, Open-market sale | 9,707 disposed | 1.91 | 18,583.08 | Form 4, filing 0001209191-22-003357 | |
| 2022-01-13 |
Imara Inc. IMRA |
S, Open-market sale | 7,209 disposed | 1.93 | 13,885.98 | Form 4, filing 0001209191-22-003357 | |
| 2022-01-12 |
Imara Inc. IMRA |
S, Open-market sale | 4,634 disposed | 2.02 | 9,357.44 | Form 4, filing 0001209191-22-003357 | |
| 2022-01-11 |
Imara Inc. IMRA |
S, Open-market sale | 2,409 disposed | 2.04 | 4,919.42 | Form 4, filing 0001209191-22-002930 | |
| 2022-01-10 |
Imara Inc. IMRA |
S, Open-market sale | 1,751 disposed | 2.00 | 3,502.00 | Form 4, filing 0001209191-22-002930 | |
| 2022-01-07 |
Imara Inc. IMRA |
S, Open-market sale | 14,600 disposed | 2.08 | 30,318.36 | Form 4, filing 0001209191-22-002930 | |
| 2022-01-06 |
Imara Inc. IMRA |
S, Open-market sale | 10,257 disposed | 2.16 | 22,205.38 | Form 4, filing 0001209191-22-002224 | |
| 2022-01-05 |
Imara Inc. IMRA |
S, Open-market sale | 8,200 disposed | 2.25 | 18,439.34 | Form 4, filing 0001209191-22-002224 | |
| 2022-01-04 |
Imara Inc. IMRA |
S, Open-market sale | 13,459 disposed | 2.34 | 31,543.86 | Form 4, filing 0001209191-22-002224 | |
| 2022-01-03 |
Imara Inc. IMRA |
S, Open-market sale | 44,665 disposed | 2.34 | 104,395.50 | Form 4, filing 0001209191-22-000354 | |
| 2021-12-31 |
Imara Inc. IMRA |
S, Open-market sale | 49,953 disposed | 2.25 | 112,409.24 | Form 4, filing 0001209191-22-000354 | |
| 2021-12-30 |
Imara Inc. IMRA |
S, Open-market sale | 21,858 disposed | 2.29 | 50,065.75 | Form 4, filing 0001209191-22-000354 | |
| 2021-12-29 |
Imara Inc. IMRA |
S, Open-market sale | 15,196 disposed | 2.30 | 34,953.84 | Form 4, filing 0001209191-21-071531 | |
| 2021-12-28 |
Imara Inc. IMRA |
S, Open-market sale | 24,580 disposed | 2.34 | 57,539.32 | Form 4, filing 0001209191-21-071531 | |
| 2021-12-27 |
Imara Inc. IMRA |
S, Open-market sale | 27,651 disposed | 2.42 | 67,006.67 | Form 4, filing 0001209191-21-071531 | |
| 2021-12-23 |
Imara Inc. IMRA |
S, Open-market sale | 23,961 disposed | 2.41 | 57,746.01 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-22 |
Imara Inc. IMRA |
S, Open-market sale | 20,109 disposed | 2.32 | 46,679.02 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-21 |
Imara Inc. IMRA |
S, Open-market sale | 41,222 disposed | 2.32 | 95,804.05 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-20 |
Imara Inc. IMRA |
S, Open-market sale | 47,000 disposed | 2.21 | 103,884.10 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-20 |
Imara Inc. IMRA |
S, Open-market sale | 38,123 disposed | 2.33 | 88,719.85 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-16 |
Imara Inc. IMRA |
S, Open-market sale | 44,993 disposed | 2.23 | 100,545.86 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-15 |
Imara Inc. IMRA |
S, Open-market sale | 28,817 disposed | 2.28 | 65,685.47 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-14 |
Imara Inc. IMRA |
S, Open-market sale | 15,093 disposed | 2.56 | 38,642.61 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-13 |
Imara Inc. IMRA |
S, Open-market sale | 17,501 disposed | 2.83 | 49,557.58 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-10 |
Imara Inc. IMRA |
S, Open-market sale | 8,667 disposed | 2.83 | 24,541.48 | Form 4, filing 0001209191-21-071262 | |
| 2021-12-09 |
Imara Inc. IMRA |
S, Open-market sale | 5,666 disposed | 2.95 | 16,693.17 | Form 4, filing 0001209191-21-071262 | |
| 2020-05-20 |
Surface Oncology, Inc. SURF |
S, Open-market sale | 420,000 disposed | 3.66 | 1,535,562.00 | Form 4, filing 0001209191-20-031786 | |
| 2020-03-16 |
Imara Inc. IMRA |
P, Open-market purchase | 475,000 acquired | 16.00 | 7,600,000.00 | Form 4, filing 0001209191-20-019337 | |
| 2020-03-06 |
Champions Oncology, Inc. CSBR |
S, Open-market sale | 708,155 disposed | 6.99 | 4,950,003.45 | Form 4, filing 0001209191-20-017699 | |
| 2020-02-10 |
Casper Sleep Inc. CSPR |
P, Open-market purchase | 1,250,000 acquired | 12.00 | 15,000,000.00 | Form 4, filing 0001209191-20-008757 | |
| 2019-11-12 |
Galera Therapeutics, Inc. GRTX |
P, Open-market purchase | 416,666 acquired | 12.00 | 4,999,992.00 | Form 4, filing 0001209191-19-056068 | |
| 2019-11-04 |
Oyster Point Pharma, Inc. OYST |
P, Open-market purchase | 935,000 acquired | 16.00 | 14,960,000.00 | Form 4, filing 0001209191-19-055017 | |
| 2019-08-28 |
Mersana Therapeutics, Inc. MRSN |
S, Open-market sale | 1,211 disposed | 2.91 | 3,524.01 | Form 4, filing 0001209191-20-024272 | |
| 2019-03-05 |
Mersana Therapeutics, Inc. MRSN |
P, Open-market purchase | 3,750,000 acquired | 4.00 | 15,000,000.00 | Form 4, filing 0001209191-19-017378 | |
| 2018-09-07 |
Adaptimmune Therapeutics PLC ADAP |
P, Open-market purchase | 3,000,000 acquired | 1.67 | 5,000,100.00 | Form 4, filing 0001209191-18-050279 | |
| 2018-04-23 |
Surface Oncology, Inc. SURF |
P, Open-market purchase | 133,333 acquired | 15.00 | 1,999,995.00 | Form 4, filing 0001209191-18-025843 | |
| 2018-03-27 |
Tracon Pharmaceuticals, Inc. TCON |
P, Open-market purchase | 707,964 acquired | 2.70 | 1,911,502.80 | Form 4, filing 0001209191-18-021747 | |
| 2018-03-27 |
Adaptimmune Therapeutics PLC ADAP |
P, Open-market purchase | 6,000,000 acquired | 1.92 | 11,500,200.00 | Form 4, filing 0001209191-18-021936 | |
| 2018-03-26 |
Adaptimmune Therapeutics PLC ADAP |
P, Open-market purchase | 571,164 acquired | 1.90 | 1,087,553.37 | Form 4, filing 0001209191-18-021936 | |
| 2018-03-23 |
Adaptimmune Therapeutics PLC ADAP |
P, Open-market purchase | 294,090 acquired | 1.95 | 572,357.96 | Form 4, filing 0001209191-18-021542 | |
| 2018-03-22 |
Adaptimmune Therapeutics PLC ADAP |
P, Open-market purchase | 869,574 acquired | 1.90 | 1,655,668.90 | Form 4, filing 0001209191-18-021542 | |
| 2018-03-21 |
Adaptimmune Therapeutics PLC ADAP |
P, Open-market purchase | 104,844 acquired | 1.81 | 189,820.06 | Form 4, filing 0001209191-18-021542 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 2
- Open-market sale 0
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. New Enterprise Associates 14, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001544328
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6